ValuentumAd

Official PayPal Seal
Valuentum Reports













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Jun 2, 2015
Medtronic On Track with Covidien Integration
We liked Medtronic before its acquisition of Covidien, and we continue to like the company now.
Mar 5, 2015
These Valuations Are Embarrassing
Airbnb? Uber? Xiaomi? Palantir? What?
Nov 18, 2014
Medtronic Surpasses $70 Per Share
The Dividend Growth portfolio holding continues to defy gravity.
Sep 2, 2014
The Dividend Dilemma
Remember that you’re putting your hard-earned capital at risk for an income stream. Be sure to keep your guard up.
Aug 26, 2014
Price Is Almost Always Different Than Value
This key tenet behind stock market investing success is worth remembering.
Jun 22, 2014
Valuentum Economic Castle™ Rating Update
Members should expect the initial Economic Castle™ ratings.
Jun 17, 2014
Firms Leaving United States for More Reasonable Tax Rates Elsewhere
Medtronic is the latest firm to pursue tax inversion via its tie-up with Covidien. Importantly, however, the firm renewed its commitment to dividend growth shareholders, hiking the payout 9%.
Jun 9, 2014
The M&A Environment Remains Robust
Let’s take a look at a few deals that hit the wires recently – some proposed, some speculated.
Apr 4, 2014
Focus on a Rules-Based Process Not on Short-term Outcomes
Let’s walk through why having a repeatable, measurable process is important.
Mar 18, 2014
Focus on Process over Outcome
We wanted to share an excellent piece on the importance of focusing on process over outcome in investing.


Latest News and Media
The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.